Researchers at the Keck School of Medicine of USC and the Cleveland Clinic Florida Research and Innovation Center have published studies focused on GRP78, a protein implicated in both COVID-19 and multiple types of cancer, and a drug that interferes with its effects.
Two recent studies by researchers from Regenstrief Institute and the Indiana University School of Medicine explore the effect of the pandemic on colorectal cancer screening tests and diagnostic colonoscopies in central Indiana.
